Yim Rebecca M, Singh Indira, Armstrong April W
Department of Dermatology, University of Southern California, Los Angeles, CA.
Dermatol Online J. 2020 Oct 15;26(10):13030/qt0j5150df.
Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential risk of SARS-CoV-2 infection. This article includes an overview of the up-to-date international and U.S. treatment guidelines for psoriasis, atopic dermatitis, hidradenitis suppurativa, and acne/rosacea; it provides tables summarizing these resources to assist providers and patients in remaining updated regarding recommended treatment modifications during the pandemic (See Tables 1-4).
由于不断演变的新型冠状病毒肺炎疫情以及关于炎症性皮肤病免疫抑制疗法的新数据，皮肤科医生被鼓励重新评估患者的治疗方案，以尽量降低感染严重急性呼吸综合征冠状病毒2的任何潜在风险。本文概述了银屑病、特应性皮炎、化脓性汗腺炎和痤疮/酒渣鼻的最新国际和美国治疗指南；提供了表格总结这些资源，以帮助医疗服务提供者和患者在疫情期间及时了解推荐的治疗调整（见表1-4）。
